Recently, an immunohistochemistry and qRT-PCR-based screening on 133 selected patients with prostate adenocarcinoma showed association of high expression of TLR3, 4 and 9 with PCa recurrence 46. This evidence concerns the gene TLR3 and posterior cortical atrophy.